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A preponderance of patients selected "When gripping objects 
with your hands" as the most important pain item (40%); where- 
as "Opening a new jar" was the most important physical function 
item (29%). 
Conclusion: In OA patients treated for 3 months, RO 25 mg qd 
exhibited superior Gt tolerability compared with NA 500 mg bid. 
In patients with hand OA, RO and NA provided similar efficacy 
whether assessed by PGADS or by the AUSCAN Hand Index, 
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Aims: A review of the literature has revealed little clinical interest 
in OA of the elbow with its occurrence being reported as uncom- 
mon. However, clinical studies investigate exclusively sympto- 
matic joints and asymptomatic pathological involvement of joints 
will go unreported. Skeletal material provides an opportunity for 
studying the pathology of OA more fully. Eburnation and osteo- 
phytes, both pathologies associated with OA, are easily seen on 
skeletal remains; we have therefore aimed to estimate the preva- 
lence of OA pathologies of the elbow using a skeletal collection. 
Methods: 563 skeletons, excavated from one site in the UK, were 
used in this study. The radio-humeral (RHJ) and ulno-humeral 
(UHJ) joints were examined by one, experienced palaeopatholo- 
gist. The presence of eburnation and osteophytes were noted. 
Standard anthropological techniques were used to age ( <45 
years or >45 years) and sex the skeletons. 
Results: 48% of the sample were female and 37% were estimat- 
ed to be over 45 years at death. The prevalence of eburnation and 
osteophytes anywhere in the elbow was 4.2% and 16.5% 
respectively. Four individuals (17.4%) with eburnation did not 
have osteophytes. Eburnation was significantly more common in 
the RHJ than the UHJ (3.7% vs 0.9%; McNemar's o~ 2 10.7. 
p<0.001) yet osteophytes were significantly more common in the 
UHJ than the RHJ (13.6% vs 9.3%; McNemar's (j2 =10.4, p<0.00 
1). Osteophytes anywhere in the elbow were significantly more 
common in the older age group than younger (28.2% vs 9.7%, (u 2 
= 24.5, p<0.001) and in males than females (22.7% vs 9.8%, (~2 = 
16.1, p<0.001). Eburnation of the elbow was significantly more 
prevalent in the older age group than younger (1.5% vs 8.3%, e) ?- 
= 11.9, p<0.001) and more prevalent in males than females but not 
significantly so (5.4% vs 2.7%, (~2 = 2.4, p=0. 120). 
Conclusion: The prevalences estimated here are comparable 
with those of the hip and knee from other skeletal studies. These 
data, therefore, raise an important issue in our understanding of 
OA: the elbow is commonly affected pathologically - but by what 
mechanism is it spared symptomatically? 
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Some anthraquinones (AQ) are used for the treatment of 
osteoarthritis (OA). We have synthesized some AQ from the par- 
ent compound anthraquinone 2,6-disulfonic acid (GR373). We 
have investigated the activity of anthraquinone 2,6-disulfonic acid 
(GR373); N,N-diethyl anthraquinone 2,6-disulfonamide(GR375) 
and 2,6-diphenetidin anthraquinone disulfonamide(GR377) on 
cathepsin B(cat-B), cathepsin L (cat-L), cyclooxygenase I (COX1) 
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and 2 (COX2), nitric oxide synthase (NOS) activities and on pro- 
teoglycan(PG)-release in cultured articular cartilage. 
Inhibition studies on cat-B and cat-L were carried out using vari- 
ous natural and synthetic substrates. COX1 and COX2 activities 
were determined in human blood after coagulation or after 24 h 
of LPS stimulation measuring TXB2 and PGE2 concentrations 
respectively. Human inducible NOS activity was measured by the 
formation of citrulUne from labeled arginine. 
Pieces of bovine articular cartilage were cultured in the presence 
or in the absence of IL-11]. PG content in both the medium and 
cartilage was assayed at various times. All the above tests have 
been carried out in the absence and in the presence of various 
concentrations of the AQ under investigation. 
The three tested AQ inhibited in a dose-dependent way both 
human cat-B and cat-L at micromolar concentrations. However 
the introduction of the above reported chemical groups on the 
parent compound GR373 greatly increases the inhibitory activity. 
The rank order of inhibition on both enzymes is 
GR377>GR375>GR373. Kinetic studies show that the inhibition 
is of the uncompetitive type. The tested AQ have no effect on 
COX1 while they inhibit COX2 and NOS at micromolar concen- 
trations. IL-Ib-induced PG release is significantly decreased by 
the tested AQ at micromolar concentrations, 
These results suggest that this novel class of AQ and in particu- 
lar the more active GR377 and GR375 have potential applica- 
tions in the treatment of OA since they may interfere with OA 
processes at different levels. 
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Aim and Methods: This study compared the efficacy and safety 
of two osteoarthritis treatments in a randomized, double-blind 
design utilizing skeletally mature dogs with osteoarthritis. The 
treatments were Cartrophen Vet (CVI, 100mg pentosan polysul- 
fate sodium/ml, 3mg/kg body weight, 4 x weekly injectlons sc; n 
= 53) and carprofen (NSAID, 4mg/kg body weight, 28 x daily cap- 
sules orally, n = 51) with appropriate placebos. Dogs were 
assessed by clinical examination at baseline and at Weeks 2, 3, 4 
and 8. 
Results: Analysis of the primary outcomes of lameness, pain and 
orthopaedic score, revealed that there was statistically significant 
improvement following treatment with CVI compared to treatment 
with NSAID at Week 8 (4 weeks after treatment had ceased) in 
orthopaedic score (p=0.013). Improvement following NSAID 
treatment relative to CVI treatment was statistically significant for 
lameness at Week 2 (p.<0.001), pain at Week 2 (p=0.023) and 
Week 3 (p<0.001) and orthopaedic score at Week 2 (p=0.041). The 
statistically significant difference at Week 2 for lameness in favor 
of NSAID was diminished by Week 8 with CVl the more favorable 
treatment (p=0.129). According to the primary outcome veterinar- 
ians' impression of the overall response to treatment, both CVl 
and NSAID treatments were highly effective and there was no sta- 
tistically significant difference between the two drugs (p=0.909). 
There was, however, a slight advantage in favor of CVI in the esti- 
mate of the magnitude of the effect. Analysis of the activity of 
each treatment compared with the corresponding baseline value 
demonstrated that both CVI and NSAID were very effective treat- 
ments with statistically significant improvements in all primary 
outcome parameters (lameness, pain and orthopaedic score) at 
all weeks (p<0.05). The efficacy of each treatment was also 
demonstrated for secondary outcomes with significant improve- 
ments in gait stiffness and get up and go at all weeks and gait 
